Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

SI-613 Study for Knee Osteoarthritis

ClinicalTrials.gov ID: NCT03209362

Public ClinicalTrials.gov record NCT03209362. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 3:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Repeated Intra-Articular Injection of SI-613 in Patients With Osteoarthritis of the Knee

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of the study is to evaluate the efficacy and safety of intra-articular injections of SI-613 compared with placebo for knee OA.

Study identification

NCT ID
NCT03209362
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Seikagaku Corporation
Industry
Enrollment
80 participants

Conditions and interventions

Interventions

Combination Product

Eligibility (public fields only)

Age range
40 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 18, 2017
Primary completion
Aug 16, 2018
Completion
Nov 12, 2018
Last update posted
Nov 3, 2021

2017 – 2018

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Tucson Orthopaedic Institute Tucson Arizona 85712
MM Medical Center, Inc. Miami Florida 33185
Quality Research and Medical Center, LLC Miami Florida 33186
Heartland Research Associates, LLC Newton Kansas 67114
Central Kentucky Research Associates Lexington Kentucky 40509
Sundance Clinical Research, LLC St Louis Missouri 63141
Rochester Clinical Research Rochester New York 14609
Upstate Clinical Research Associates, LLC Williamsville New York 14221
New Horizons Clinical Research Cincinnati Ohio 45242
Altoona Center for Clinical Research Duncansville Pennsylvania 16635

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03209362, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 3, 2021 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03209362 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →